Skip to main content
. 2019 Mar 19;197(3):285–293. doi: 10.1007/s00408-019-00215-6

Table 2.

Objective and subjective assessments of physical activity in participants with sarcoidosis and healthy controls

Healthy controls (n = 14) Sarcoidosis (n = 15)
Objective assessments
 6MWD (m) 487 (92) 375 (59)*
Physical activity
 Step counts (/day) 10,429 (2942) 5624 (1875)
 Sit to stand transitions (/day) 63 (47–69) 53 (35–59)
 Upright time (h/day) 5.69 (5.26–6.47) 5.71 (3.73–7.56)
  Stepping time (h/day) 1.86 (1.73–2.23) 1.17 (0.99–1.55)
  Standing time (h/day) 3.77 (3.48–4.60) 4.16 (2.86–6.27)
Subjective assessments
 IPAQ scores
  Overall (MET-min/week) 3230 (1912–5599) 2153 (1152–4925)
  Walking (MET-min/week) 1287 (412–1914) 1386 (330–3366)
  Moderate PA (MET-min/week) 840 (210–1510) 320 (127–2175)
  Vigorous PA (MET-min/week) 480 (0–3360) 0 (0–0)

Data presented as mean (SD) or median (IQR)

6MWD 6-min walk distance; IPAQ International Physical Activity Questionnaire; MET metabolic equivalent

*p = 0.0009

p < 0.0001

p = 0.017